Single Gemcitabine Instillation Can Reduce Urothelial Cancer Recurrence
An intravesical instillation of gemcitabine following TURBT reduced the risk of recurrence in patients with suspected low-grade non –muscle-invasive urothelial cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 14, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Bladder Cancer Genitourinary Cancers SiteTerms/www.cannabissciencetech.com/News Source Type: news

Mother, 32, who delayed skin cancer treatment for unborn twins has died 10 months after giving birth
At just 17 weeks' gestation, tests revealed Kansas-based Danielle Dick - who had been declared 'all-clear' of skin cancer five years earlier - had stage 4 melanoma. She died on April 26. (Source: the Mail online | Health)
Source: the Mail online | Health - May 14, 2018 Category: Consumer Health News Source Type: news

Adjuvant Chemotherapy Key to Improving OS in Rectal Cancer
Retrospective study shows 30 patients need to be treated with adjuvant therapy to prevent a death at 3 years. (Source: CancerNetwork)
Source: CancerNetwork - May 14, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer News Source Type: news

Risk Models Help Select Ever Smokers for Lung CA Screening
MONDAY, May 14, 2018 -- Four lung cancer risk models perform best in selecting ever-smokers for screening, according to a study published online May 15 in the Annals of Internal Medicine. Hormuzd A. Katki, Ph.D., from the National Cancer Institute... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 14, 2018 Category: Pharmaceuticals Source Type: news

U.K. group uses math to characterize lung disease on CT
Researchers from the U.K. have developed a method that uses a combination of...Read more on AuntMinnie.comRelated Reading: Genetic variation in lung airways elevates risk of COPD AI algorithm predicts lung disease, adverse events on CT Advanced visualization tool assesses lung disease COPD severity mirrors lung cancer incidence AJR: Ultralow-dose CT can evaluate COPD (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 14, 2018 Category: Radiology Source Type: news

Dying Erika Zak pens letter to insurer that denied her a liver
Surgery to remove tumors on her liver from stage 4 colon cancer left Erika Zak of Oregon with a hole in the organ which is now failing the young mother, but her insurance refused to cover a transplant. (Source: the Mail online | Health)
Source: the Mail online | Health - May 14, 2018 Category: Consumer Health News Source Type: news

What Causes Cancer? Misconceptions Abound
MONDAY, May 14, 2018 -- Many people are clueless about what can actually cause cancer, a new study finds. Not stress, microwave ovens or food additives, British experts say. But a survey of more than 1,300 people in England found many folks believe... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 14, 2018 Category: General Medicine Source Type: news

Teledermatology Could Expedite Care for Suspected Skin Cancer
Australian study finds implementation significantly speeds time to clinical resolution (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 14, 2018 Category: Cancer & Oncology Tags: Dermatology, Family Medicine, Oncology, Journal, Source Type: news

UCLA engineer develops 3D printer that can create complex biological tissues
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.“Tissues are wonderfully complex structures, so to engineer artificial versions of them that function properly, we have to recreate their complexity,” said Ali Khademhosseini, who led the study and is UCLA’s Levi James Knight, Jr., Professor of Engineering at theUCLA Samueli School of Engineering. “Our new approach offers ...
Source: UCLA Newsroom: Health Sciences - May 14, 2018 Category: Universities & Medical Training Source Type: news

Chemo-Induced Neuropathy Common after Childhood Cancer
(MedPage Today) -- Neurotoxicity more prevalent in children treated with cisplatin (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 14, 2018 Category: Hematology Source Type: news

Multigene Sequencing Rapidly Replacing BRCA Tests Multigene Sequencing Rapidly Replacing BRCA Tests
Among women diagnosed with breast cancer, during the past 2 years, the use of multigene testing has risen dramatically, while testing only for BRCA mutations has dropped.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Immunicom's Immunotherapy Product Receives U.S. FDA Breakthrough Device Designation for the Treatment of Cancer
SAN DIEGO, May 14, 2018 -- (Healthcare Sales & Marketing Network) -- Immunicom, Inc., a medical technology company developing revolutionary non-pharmaceutical approaches for treating cancer and autoimmune diseases, has received Breakthrough Device designa... Devices, Oncology, FDA Immunicom, Immunopheresis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: Deadly brain cancer stopped with new compound
New research shows that using an experimental enzyme-blocker stops brain tumors from growing and limits the ability of human cancer cells to replicate. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 14, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Breast cancer warning - five symptoms that you should never ignore
BREAST cancer symptoms usually begin with a lump, but all signs should be checked by a doctor. These are the symptoms you should never ignore - is pain one of the symptoms of a deadly tumour? (Source: Daily Express - Health)
Source: Daily Express - Health - May 14, 2018 Category: Consumer Health News Source Type: news

Predictors of falls in older survivors of breast and prostate cancer: A retrospective cohort study of surveillance, epidemiology and end results-Medicare health outcomes survey linkage - Huang MH, Blackwood J, Godoshian M, Pfalzer L.
OBJECTIVES: To identify predictors of falls in older breast and prostate cancer survivors. METHODS: This retrospective cohort study analyzed population-based Surveillance, Epidemiology and End Results-Medicare Health Outcomes Survey (SEER-MHOS) lin... (Source: SafetyLit)
Source: SafetyLit - May 14, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Vinay Prasad: Why I'm Writing for Medscape Vinay Prasad: Why I'm Writing for Medscape
Vinay Prasad introduces his new Medscape column.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology Viewpoint Source Type: news

Study Reveals Emotional Needs of People Exposed to Asbestos
There is very little information available on the psychological care needs of people with malignant mesothelioma. Even less is known about people who have been exposed to asbestos but do not have mesothelioma. A newly published systematic research review sheds light on the distress people experience in these situations. In March 2018, the American Journal of Industrial Medicine published an article highlighting the need for additional studies. Researchers described what is known about asbestos-affected people and how and why they experience so much mental and emotional distress. Most Affected People Exposed Through Work Th...
Source: Asbestos and Mesothelioma News - May 14, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

GT Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
LOS ANGELES, May 14, 2018 -- (Healthcare Sales & Marketing Network) -- GT Biopharma Inc. (OTCQB: GTBP)(Euronext Paris GTBP.PA) today announced the promotion of Dr. Raymond W Urbanski MD, PhD to the position of President and Chief Medical Officer effective... Biopharmaceuticals, Oncology, Personnel GT Biopharma, Natural Killer Cell Engagers (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

Lilly to Acquire AurKa Pharma
Acquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor Types INDIANAPOLIS, May 14, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire A... Biopharmaceuticals, Oncology, Mergers & Acquisitions Eli Lilly, AurKa Pharma, Aurora kinase A inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2018 Category: Pharmaceuticals Source Type: news

First description of mEAK-7 gene could suggest path toward therapies for cancer, other diseases
For years, researchers have known that a gene called EAK-7 plays an important role in determining how long worms will live. But it remained unclear whether the gene had a counterpart in humans and – if it did – how that human version would work.Now, researchers led by UCLA ’sDr. Paul Krebsbach are the first to characterize the mechanism of the human equivalent, which they call mammalian EAK-7, or mEAK-7.Krebsbach, dean of theUCLA School of Dentistry and a professor of periodontics, led a team that found mEAK-7 regulates the molecular process, or “metabolic pathway,” that dictates cell growth a...
Source: UCLA Newsroom: Health Sciences - May 14, 2018 Category: Universities & Medical Training Source Type: news

Teledermatology Could Expedite Care for Suspected Skin Cancer
MONDAY, May 14, 2018 -- Teledermatology for suspected skin cancer is slightly more expensive than usual care, but it expedites time to clinical resolution, according to a study published online May 9 in JAMA Dermatology. Centaine L. Snoswell,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 14, 2018 Category: Pharmaceuticals Source Type: news

Overall, Drinking Wine Does Not Impact Prostate Cancer Risk
MONDAY, May 14, 2018 -- Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 in Clinical Epidemiology. Mihai Dorin Vartolomei, Ph.D., M.D., from the University of Medicine and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 14, 2018 Category: Pharmaceuticals Source Type: news

Eat more dark chocolate to resolve irregular heartbeats
(Natural News) Chocolate lovers, rejoice: A study published in the journal Heart has found that eating moderate amounts of chocolate can reduce the risk of developing atrial fibrillation (AFib), a life-threatening form of irregular heartbeat. Scientists at the Beth Israel Deaconess Medical Center, together with the Harvard T.H. Chan School of Public Health, Aalborg University, and the Danish Cancer... (Source: NaturalNews.com)
Source: NaturalNews.com - May 14, 2018 Category: Consumer Health News Source Type: news

Eliminating the Hepatitis B Virus and Hepatitis C Virus to Reduce New Cases of Liver Cancer
May 16, 2018 2:00-3:30pm ET. (Source: PHPartners.org)
Source: PHPartners.org - May 14, 2018 Category: International Medicine & Public Health Source Type: news

Medical News Today: Can women get prostate cancer?
Women do not have a prostate in the same way as men. They do, however, have Skene glands, often called the female prostate, which have many similarities to the prostate. Cancer of the female prostate is extremely rare. Find out about the functions of the Skene glands and learn more about female prostate cancer here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 14, 2018 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Mercy Health to pay $14M settlement
Mercy Health has agreed to pay $14.25 million to the U.S. government to settle allegations that it violated the False Claims Act. According to a statement from the U.S. Department of Justice, Mercy self-disclosed improper financial relationships with referring physicians including one oncologist and five internal medicine physicians who received compensation that exceeded fair market value for their services. "During an int ernal audit, Mercy Health learned that it made errors in the administration… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 14, 2018 Category: Pharmaceuticals Authors: Erin Caproni Source Type: news

Targeting AXL Could Slow Metastasis in HER2-Positive Breast Cancer
New research has found that expression of AXL is correlated with poor outcomes in patients with HER2-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 14, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Tessa Jowell cancer: How did she die? Symptoms of politician’s deadly tumour
TESSA JOWELL, a British Labour Party politician, died on Saturday after losing her battle with brain cancer. Symptoms of the disease depend on the exact part of the brain that has been affected, but common signs to watch out for include two persistent health issues. (Source: Daily Express - Health)
Source: Daily Express - Health - May 14, 2018 Category: Consumer Health News Source Type: news

Tumor-like spheres help scientists discover smarter cancer drugs
Cancer is a disease often driven by mutations in genes. As researchers learn more about these genes, and the proteins they code for, they are seeking smarter drugs to target them. The ultimate goal is to find ways to stop cancer cells from multiplying out of control, thereby blocking the growth and spread of tumors. (Source: World Pharma News)
Source: World Pharma News - May 14, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Medigene in for up to $1.5 billion under broader pact with Bluebird Bio
FRANKFURT (Reuters) - German biotech firm Medigene has secured a wider remit under a collaboration with U.S. peer Bluebird Bio on a technology that boosts the immune response to cancer, increasing the pool of potential milestone payments to $1.5 billion. (Source: Reuters: Health)
Source: Reuters: Health - May 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Uganda:UVRI Partners With London School for Cancer Research
[Monitor] Kampala -The Medical Research Council (MRC) and the Uganda Virus Research Institute (UVRI) have partnered with the London School of Hygiene and Tropical Medicine (LSHTM) to conduct research into cancer and other non-communicable diseases (NCDs). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 14, 2018 Category: African Health Source Type: news

Medigene broadens alliance on T-cell receptors with Bluebird Bio
FRANKFURT (Reuters) - German biotech firm Medigene has secured a wider remit under a collaboration with U.S. peer Bluebird Bio on technology that boosts the immune response to cancer, increasing the pool of potential milestone payments to $1.5 billion. (Source: Reuters: Health)
Source: Reuters: Health - May 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Tessa Jowell tribute: Funding doubled for brain cancer research
Theresa May said £40m of government money would help build a "lasting legacy" for the politician. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 14, 2018 Category: Consumer Health News Source Type: news

RoomLab CEO: On Fighting Cancer, A Surprise Pregnancy And Raising Investment
“It was an enormous shock,” says Suzann Bozorgi after a deep breath. The entrepreneur is still new to talking about the breast cancer diagnosis that rocked her life. Yet her mental and physical experience of cancer have directly influenced her the two businesses she's founded. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 14, 2018 Category: Pharmaceuticals Authors: Kitty Knowles, Forbes Staff Source Type: news

Hodgkin's Lymphoma of the Breast Hodgkin's Lymphoma of the Breast
This unusual case details the diagnosis and management of Hodgkin's lymphoma which presented in a male patient as gynecomastia and breast tenderness.Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Delayed Initial Radioiodine Therapy in Thyroid Cancer Delayed Initial Radioiodine Therapy in Thyroid Cancer
The initiating time of radioiodine therapy in differentiated thyroid cancer may impact the individual response to therapy.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 14, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Researchers identify the most accurate risk prediction models for selecting whom to screen
(American College of Physicians) Four risk prediction models have been shown to be most accurate for selecting the highest risk ever-smokers for lung cancer screening. Researchers suggest that this data can be used to inform future lung cancer screening guidelines. The findings are published in Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

'Universal antibodies' disarm various pathogens
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Scientists from the German Cancer Research Center (DKFZ) have been studying how the immune system succeeds in keeping pathogens in check. For the first time, the researchers have now discovered antibodies that are capable of disarming not only one specific bacterium but a whole variety of microorganisms at once. The newly discovered antibodies recognize a tiny sugar structure found on the surface of various germs. Thus, a limited number of antibodies is sufficient to control a wide variety of microorganisms. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 14, 2018 Category: Biology Source Type: news

Study hints at new target to improve immune therapy in triple-negative breast cancer
(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center study shows that Eya3 may regulate the immune response to a tumor, implying that anti-Eya3 therapies may improve checkpoint inhibitors against triple-negative breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

Deadly cancers show early, detectable differences from benign tumors
(Duke University Medical Center) Do metastatic cancer tumors 'break bad' or are they 'born bad'? In a study publishing the week of May 14 in the Proceedings of the National Academy of Sciences, researchers found that in the colorectal tumors they examined, invasive cancers are born to be bad, and this tendency can potentially be identified at early diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer
(JAMA Network) A new study assesses chemotherapy-induced peripheral neuropathy in 121 long-term survivors of childhood cancer to detail clinical, functional, neurophysiological and patient-reported outcomes of the condition. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

Study picks out children with incurable brain cancer who could benefit from adult therapy
(Institute of Cancer Research) Children with incurable brain tumors could benefit from potentially life-extending treatment if genetic testing was used to personalize therapy as it is in many adults, major new research reports.Scientists analyzed the DNA of children taking an adult cancer drug on a clinical trial deemed to have 'failed,' and found that many with particular genetic traits had actually responded well to treatment.Some of these children survived more than a year longer than others on the trial. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

New approach to cancer research aims to accelerate studies and reduce cost
(University of Texas M. D. Anderson Cancer Center) A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical companies is being tested by research experts at The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

Better equipped in the fight against lung cancer
(University of Erlangen-Nuremberg) Lung cancer is the third most common type of cancer in Germany and the disease affects both men and women. However, immunotherapies are successful in only 20 percent of cases. Researchers at Friedrich-Alexander-Universit ä t Erlangen-N ü rnberg (FAU) have now discovered a special mechanism that regulates tumour growth in lung cancer. This opens up new possibilities in the treatment of lung cancer patients. The results were published in the journal Oncoimmunology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

Nanomedicine -- Targeting cancer cells with sugars
(Ludwig-Maximilians-Universit ä t M ü nchen) Globally, cancer is the second leading cause of death, also because the efficiency of chemotherapeutics is inadequate due to poor delivery to the tumor. Professor Olivia Merkel and her team develop targeted nanocarrier systems to increase the delivery rates of therapeutic formulations and their specific uptake into the target cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

University of Alberta cyclotron could supply province's demand for medical isotopes
(University of Alberta Faculty of Medicine& Dentistry) University of Alberta scientists have taken a critical step towards supplying Alberta's demand for medical isotopes. Their newly published findings could have major implications for other health jurisdictions across North America as well.Researchers at the university's Medical Isotope and Cyclotron Facility used a particle accelerator known as a cyclotron to produce enough isotopes for up to 1,000 diagnostic procedures in a day. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

First description of mEAK-7 gene could suggest path toward therapies for cancer
(University of California - Los Angeles) UCLA-led study has characterized the mechanism of the human equivalent of the gene, EAK-7, that plays a role in determining how long worms will live. Researchers are calling it mammalian EAK-7, or mEAK-7, and have shown that it regulates the process that dictates cell growth and human development. Findings could lead to new therapies that would work by slowing or blocking mEAK-7's process, which could control the spread and growth of cells responsible for diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

Scientists find missing factor in gene activation
(University of California - San Diego) Scientists have unraveled a mystery on how genes are activated. Human genes are blocked by structures known as nucleosomes, components that package DNA inside cells. How do these roadblocks clear out to allow genes to be turned on? Scientists have identified a key factor that unravels nucleosomes and clears the way for gene activation. They say the finding is useful in understanding diseases such as cancer, which can be caused by improper gene activity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

UTA researcher patents 'roach motel' for cancer
(University of Texas at Arlington) The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 14, 2018 Category: Biology Source Type: news

New 'Scoring' System for Advanced Colorectal Cancer
(Johns Hopkins Medicine) Georgios Margonis, M.D., Ph.D., a surgical oncology fellow at the Johns Hopkins University School of Medicine, and Matthew Weiss, M.D., surgical director of the Johns Hopkins Liver and Pancreas Cancer Multidisciplinary Clinics, report advances in efforts to improve the treatment and prognosis of colorectal cancers that have spread to the liver. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2018 Category: International Medicine & Public Health Source Type: news